165 related articles for article (PubMed ID: 22007260)
1. Rhein induces apoptosis in human breast cancer cells.
Chang CY; Chan HL; Lin HY; Way TD; Kao MC; Song MZ; Lin YJ; Lin CW
Evid Based Complement Alternat Med; 2012; 2012():952504. PubMed ID: 22007260
[TBL] [Abstract][Full Text] [Related]
2. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells.
Seo HS; Choi HS; Kim SR; Choi YK; Woo SM; Shin I; Woo JK; Park SY; Shin YC; Ko SG
Mol Cell Biochem; 2012 Jul; 366(1-2):319-34. PubMed ID: 22527937
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
4. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.
Wang J; Liu S; Yin Y; Li M; Wang B; Yang L; Jiang Y
Apoptosis; 2015 Mar; 20(3):399-409. PubMed ID: 25501496
[TBL] [Abstract][Full Text] [Related]
5. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
6. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.
Simeone AM; Broemeling LD; Rosenblum J; Tari AM
Oncogene; 2003 Oct; 22(43):6739-47. PubMed ID: 14555987
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
10. Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells.
Do MT; Hwang YP; Kim HG; Na M; Jeong HG
J Cell Physiol; 2013 May; 228(5):1087-97. PubMed ID: 23065756
[TBL] [Abstract][Full Text] [Related]
11. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
[TBL] [Abstract][Full Text] [Related]
12. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.
Faltus T; Yuan J; Zimmer B; Krämer A; Loibl S; Kaufmann M; Strebhardt K
Neoplasia; 2004; 6(6):786-95. PubMed ID: 15720805
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
Benz CC; Scott GK; Sarup JC; Johnson RM; Tripathy D; Coronado E; Shepard HM; Osborne CK
Breast Cancer Res Treat; 1992; 24(2):85-95. PubMed ID: 8095168
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Gupta P; Srivastava SK
BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
[TBL] [Abstract][Full Text] [Related]
16. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
17. Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells.
Lai WW; Yang JS; Lai KC; Kuo CL; Hsu CK; Wang CK; Chang CY; Lin JJ; Tang NY; Chen PY; Huang WW; Chung JG
In Vivo; 2009; 23(2):309-16. PubMed ID: 19414420
[TBL] [Abstract][Full Text] [Related]
18. Rhein induces liver cancer cells apoptosis via activating ROS-dependent JNK/Jun/caspase-3 signaling pathway.
Wang A; Jiang H; Liu Y; Chen J; Zhou X; Zhao C; Chen X; Lin M
J Cancer; 2020; 11(2):500-507. PubMed ID: 31897245
[No Abstract] [Full Text] [Related]
19. Rhein induces apoptosis and autophagy in human and rat glioma cells and mediates cell differentiation by ERK inhibition.
Tang N; Chang J; Lu HC; Zhuang Z; Cheng HL; Shi JX; Rao J
Microb Pathog; 2017 Dec; 113():168-175. PubMed ID: 29056497
[TBL] [Abstract][Full Text] [Related]
20. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
